“
TL;DR
This is a case report of a 48-year-old man presenting with a large, aggressive hepatoid carcinoma of the pancreas (HCP).
Hepatobiliary Surgery and Nutrition · 16 authors, 4 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This is a case report of a 48-year-old man presenting with a large, aggressive hepatoid carcinoma of the pancreas (HCP).
This is a case report of a 48-year-old man presenting with a large, aggressive hepatoid carcinoma of the pancreas (HCP). Postoperatively, he received sorafenib. The implications suggest that a multidisciplinary approach combining aggressive surgery and targeted therapy may offer a potential strategy for this rare, poor-prognosis cancer.